FBR Capital initiated coverage of Prima BioMed Ltd. (Nasdaq: PBMD) with an Outperform rating and a $6 price target. The stock price climbed 19 cents to $1.27.
Prima BioMed initiated at Outperform
December 03, 2015 at 14:23 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.